Stanford University
Showing 201-300 of 829 Results
-
Alan Schroeder
Clinical Professor, Pediatrics
BioDr. Schroeder is the associate chief for research in the division of pediatric hospital medicine at Lucile Packard Children’s Hospital Stanford, and a clinical professor in the division of hospital medicine and the division of critical care. His research interests focus on identifying areas where we can “safely do less” in healthcare, striving to ensure that children get the healthcare that they need while avoiding excessive tests and treatments that only cause harm. Dr. Schroeder is currently involved in multiple projects involving common conditions and interventions in pediatrics. He serves as the Stanford PI for PEDSNet and is an Associate Editor for the journal Hospital Pediatrics. At Stanford he co-leads the residency clinical research scholarly concentration and the faculty Clinical Research Peer Scholarship Community. Dr. Schroeder provides clinical care for children in the PICU and the pediatric ward.
-
Dustin Schroeder
Associate Professor of Geophysics, of Electrical Engineering and Senior Fellow at the Woods Institute for the Environment
BioMy research focuses on advancing the scientific and technical foundations of geophysical ice penetrating radar and its use in observing and understanding the interaction of ice and water in the solar system. I am primarily interested in the subglacial and englacial conditions of rapidly changing ice sheets and their contribution to global sea level rise. However, a growing secondary focus of my work is the exploration of icy moons. I am also interested in the development and application of science-optimized geophysical radar systems. I consider myself a radio glaciologist and strive to approach problems from both an earth system science and a radar system engineering perspective. I am actively engaged with the flow of information through each step of the observational science process; from instrument and experiment design, through data processing and analysis, to modeling and inference. This allows me to draw from a multidisciplinary set of tools to test system-scale and process-level hypotheses. For me, this deliberate integration of science and engineering is the most powerful and satisfying way to approach questions in Earth and planetary science.
-
John S. Schroeder, MD
Professor (Clinical) of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
(a) Calcium Channel Blockers
(b) Agents for Heart Failure
(c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers
2. Cardiac Transplantation/Congestive Heart Failure
3. Coronary Artery Spasm -
Joseph Schroers-Martin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMedical heme/onc focused on molecular cancer diagnostics and novel biomarkers.
-
Birgitt Schuele
Associate Professor (Research) of Pathology
Current Research and Scholarly InterestsThe Schuele lab focuses on neurogenetics, human stem cell modeling, and gene therapy approaches to uncover disease mechanisms and pathways involved in neurodegeneration in Parkinson's, Alzheimer's disease and related disorders.
-
Kevin Schulman
Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business
BioDr. Schulman is a Professor of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He serves as Interim Division Co-Chief for the Division of Hospital Medicine at Stanford, and as an Associate Chair of the Department of Medicine. He is the Faculty Director of Stanford’s new applied master degree program, the Master of Science in Clinical Informatics Management program. He also serves as Deputy Director of the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and has an appointment in the Department of Health Policy (by courtesy).
Dr. Schulman is a health economist/health services researcher working at the intersection of business, medicine and technology. With over 500 publications, he has had a broad impact on several areas of health policy (Scopus h-index=81). His research has appeared in the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the editor-in-chief of Health Management, Policy and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Service Research (HSR).
He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program. He is an elected member of ASCI and AAP. -
Kenneth Schultz
William Bennett Munro Professor of Political Science
BioKenneth A. Schultz is William Bennett Munro Professor of Political Science at Stanford University. His research examines international conflict and conflict resolution. He is the author of Democracy and Coercive Diplomacy and World Politics: Interests, Interactions, and Institutions (with David Lake and Jeffry Frieden), as well as numerous articles in peer-reviewed scholarly journals. He was the recipient the 2003 Karl Deutsch Award, given by the International Studies Association, and a 2011 Dean’s Award for Distinguished Teaching, awarded by Stanford’s School of Humanities and Sciences. He received his PhD in political science from Stanford University.
-
Liora Schultz
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
BioI am currently postdoctoral research fellow pursuing immunotherapy research in the oncology department at Stanford University. My clinical training as a pediatric hematology oncology fellow at Memorial Sloan Kettering Cancer Center highlighted the desperate need for novel therapeutic options for a subtype of aggressive pediatric leukemia, Acute Myeloid Leukemia (AML). Despite our best standard of care for AML, long term survival rates range from 50-60% with an unacceptably high relapse rate of 40%. The urgent need for novel treatments inspired me to pursue a research project in adoptive immunotherapy, genetically modifying Tcells to express artificial T cell receptors, termed chimeric antigen receptors (CARs), that target AML specific antigens. In parallel to my clinical training, I constructed an AML specific CAR and demonstrated its ability to redirect T cell function mediating eradication of AML cells. As the field of CAR therapy rapidly advances, novel methods to optimize this therapeutic modality are imperative. To this end, supported by research demonstrating superior antitumor function of naïve derived effector T cells compared to central memory derived effector T cells, I am investigating whether preferential modification of naïve T cells to express CARs will generate a T cell subpopulation with increased efficacy. Consolidating my clinical and research experiences within highly academic institutes allows me to synthesize my pursuit of scientific rigor and commitment to the field of oncology, with a mission to achieve productive research and translatable results.
-
Elizabeth Schumann
Billie Bennett Achilles Director of Keyboard Programs and Assistant Professor (Teaching) of Music
Current Research and Scholarly InterestsAs a concert pianist, I deeply value the rich traditions of classical music. My passion lies in blending this artistry with scientific insights from neuroscience to biomechanics. This isn't solely about music; it's about applying lessons about optimal practice and peak performance to life's broader canvas. Through my research, I strive to evolve musical training, paving the way for the next generation of dedicated and resilient performers.
-
Molly Schumer
Assistant Professor of Biology
BioMolly Schumer is an Assistant Professor in Biology. She is interested in genetics and evolutionary biology. After receiving her PhD at Princeton, she did her postdoctoral work at Columbia and was a Junior Fellow in the Harvard Society of Fellows and Hanna H. Gray Fellow at Harvard Medical School. Current research in the lab centers on understanding the genetic mechanisms of evolution, with a focus on natural populations.
-
Philip Schuster
Professor of Particle Physics and Astrophysics
BioProfessor Schuster is a theoretical physicist focused on identifying dark matter and its properties, developing concepts for new experimental tests of physics beyond the Standard Model, and studying novel theories of long-range forces. He is also directly involved in several experimental efforts as co-spokesperson for APEX, a founding member and physics coordinator for LDMX, and as a founding member of HPS.
Prospective graduate students interested in research rotations should contact Professor Schuster directly. Recent research directions include new ideas to detect axions, milli-charge dark matter, the use of novel accelerator experiments to search for light WIMP-like dark matter, and generalizations of gauge theories that include massless particles with continuous spin. Publications are listed on INSPIRE.
Professor Schuster is also chair of the Particle Physics & Astrophysics department at Stanford’s SLAC National Accelerator Laboratory. -
Daniel Schwartz
Dean of the Graduate School of Education and the Nomellini & Olivier Professor of Educational Technology
Current Research and Scholarly InterestsInstructional methods, transfer of learning and assessment, mathematical development, teachable agents, cognition, and cognitive neuroscience.
-
Neil Schwartz, MD, PhD
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsMy clinical interests involve inpatient and outpatient care of patients with neurovascular diseases, mostly ischemic and hemorrhagic stroke. I have a particular interest in cervical artery dissection, non-atherosclerotic vasculopathies, and stroke in the young.
-
Jennifer Schwartz Poehlmann
Senior Lecturer of Chemistry
BioReaching out to Stanford’s diverse body of students and beyond to share the excitement of scientific discovery has been a growing passion for Dr. Jennifer Schwartz Poehlmann. In addition to coordinating and co-teaching Stanford’s freshmen chemistry sequence, she takes a leadership role in developing training programs for teaching assistants and enhancing classroom and lab experiences for undergraduates, while also providing STEM learning opportunities for incoming freshmen and local high school students.
Jennifer Schwartz Poehlmann studied chemistry at Washington University in Saint Louis Missouri (A.B. 2002) before coming to Stanford University as a graduate student (Ph.D. 2008). Her thesis work under Prof. Edward Solomon addressed structural contributions to reactivity in active sites of non-heme di-iron enzymes, including ferritins. She joined the Stanford Center (now Vice Provost) for Teaching and Learning as a Teaching Fellow in 2008. In 2009, she became Lecturer and Introductory Course Coordinator for the Department of Chemistry, and in 2011 was promoted to Senior Lecturer. She has received multiple awards for her teaching and training work, including the Walter J. Gores Award for Excellence in Teaching, Dean’s Award for Achievements in Teaching, Hoagland Award Fund for Innovations in Undergraduate Teaching, and Society of Latino Engineers and School of Engineering’s Professor of the Year Award.
Teaching
Dr. Schwartz coordinates and co-teaches the introductory course sequence of Chem31A, 31B, and 33 for about 450 students each year. She has also created a set of companion courses (Chem31A-C, 31B-C, and 33-C) designed to provide motivated students an opportunity to build stronger study habits and problem solving tools that help them persevere in the sciences regardless of prior science background. In parallel, she has been involved in the creation and teaching of the Leland Scholars Program, which facilitates the transition to college for incoming freshman intending to study in STEM or pre-health fields.
Instructor Training
Dr. Schwartz has always believed that well-prepared and enthusiastic teachers inspire and motivate learning, yet excellent teaching requires training, feedback, reflection and support. She has worked both within the department and more broadly to help ensure that teaching assistants throughout the university receive the training, practice and mentorship they need to grow and excel as educators. She previously directed the Department of Chemistry’s TA Training program and, with the Vice Provost for Teaching and Learning, co-founded and directs the Mentors in Teaching Program, MinT, which provides training and resources to teaching mentors from more than 15 departments on campus. Through MinT, advanced graduate students learn effective ways to mentor TAs, through mid-quarter feedback, classroom observation, establishment of teaching goals, and workshops that enable new TAs to better engage with students in the classroom.
Enhanced Learning Experiences
Dr. Schwartz has been heavily involved in the development of hands-on, guided-inquiry lab activities that are now fully integrated into lab/lecture courses throughout the introductory general and organic chemistry sequence. Through the “Inspiring Future Scientists in Chemistry” Outreach Program, she is also helping to bring the excitement of exploring real-world chemistry into local high schools. She works with local high school teachers to design lab experiences that reinforce and compliment the chemistry concepts in the California State curriculum. Stanford Chemistry students take these activities to local high schools, providing hundreds of students the opportunity to work with enthusiastic young scientists while getting hands-on experience in chemistry. The program aims to demonstrate how chemistry relates to the ‘real world’ and to promote an appreciation for both science and higher education. -
H Schwettman
Professor of Physics, Emeritus
BioAlan received his PhD from Rice University. He has acted as a research associate, associate professor, and professor at Stanford University. Research interests include the development of optical techniques that exploit the unique capabilities of the Free Electron Laser (FEL) in materials and biomedical research.
-
Christopher Thomas Scott, PhD
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsMy research focuses on the political, legal, ethical and economic impacts of stem cell research. Topics include: embryonic and adult stem cell research and clinical trials, stem cell banking, human-animal chimeras; cell and gamete donation; international perspectives of bioethics; global economic impacts; national and state regulatory policy, stem cell entrepreneurship, intellectual property and offshore stem cell transplants.
-
Jake Scott
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.
Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.
One of Dr. Scott’s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
He is the medical director of the Antimicrobial Stewardship Program at Stanford Health Care – ValleyCare in Pleasanton and is a member of the Infection Control Committee and the Stanford Vaccine Clinical Advisory Committee.
In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his wife and two young children. -
Matthew P. Scott
Professor of Developmental Biology, Emeritus
Current Research and Scholarly InterestsOur research has been focused on the genetic regulation of animal development and its relation to birth defects, cancer, and neurodegeneration. We studied mechanisms and functions of Hedgehog (Hh) signaling, which controls cell fates and growth, in the context of normal development and brain cancer. We studied a neurodegenerative disease, Niemann-Pick C syndrome, that affects intracellular organelle movements and sterol homeostasis. Due to Dr. Scott's new job, the lab is no longer active.
-
Katharine Sears Edwards
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.
Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).
Assessment and training in evidence-based psychological therapies. -
Vittorio Sebastiano
Associate Professor (Research) of Obstetrics and Gynecology (Reproductive and Stem Cell Biology)
Current Research and Scholarly InterestsThe thread of Ariadne that connects germ cells, preimplatation development and pluripotent stem cells is the focus of my research, with a specific interest in human development. My long-term goals are: 1. Understanding the biology of germ cells and and their ability to sustain early preimplantation development; 2. Understanding the mechanisms that regulate very early cell fate decisions in human embryos; 3. Understanding the biology of derivation and maintenance of Pluripotent Stem Cells
-
Brian Sedar
Adjunct Professor
Bio35 years of experience in EPC work spanning project controls, procurement, project development, construction, project management and operations. Bechtel Partner and Project Director for three of Bechtel’s largest international transportation infrastructure projects (click on Projects under Research), High Speed 1 in the UK, Hamad International Airport in Qatar and Upgrades for three London Underground lines. Served as General Manager of Bechtel’s Telecoms & Industrial business, Global Procurement Manager and launched its Global Water business. Now one of Stanford's most experienced construction practitioner-instructors.
-
Talal Seddik
Clinical Associate Professor, Pediatrics - Infectious Diseases
Current Research and Scholarly InterestsTalal Seddik is a member of the Collaborative Antiviral Study Group. He is the key site investigator at the Stanford site for the following multicenter studies:
1) DMID 19-0026 Enterovirus Study
Neonatal Enterovirus and Human Parechovirus Viral Sepsis: Natural History and Predictors of Morbidity and Mortality
This study will be the first large, multi-state prospective assessment of the viral causes of neonatal sepsis conducted. The main reason for this research study is to get a better understanding of what causes neonatal viral sepsis and to assess the impact of the infection on the babies’ health. Viruses called enterovirus (EV) or human parechovirus (HPeV) are very common in the population and can cause neonatal viral sepsis. By gaining a better understanding of the condition, we hope this information can be used to guide diagnosis and treatment of babies with neonatal viral sepsis in the future.
This study is actively enrolling subjects
2) DMID 19-0005 Acute Flaccid Myelitis (AFM) Study
A Prospective Study of Acute Flaccid Myelitis (AFM) to Define Natural History, Risk Factors and Pathogenetic Mechanisms
Patients with suspected AFM (onset of flaccid limb weakness within the previous 30 days) are eligible to enroll in the study. Investigators will assess participants at four-time points within the first month of enrollment and will ask participants to return for additional follow up visits at 3 months, 7 months and 1 year. Neurologic improvements will be tracked over time, and samples will be collected and stored in a biorepository for use in future research studies. Household contacts, such as siblings, will be eligible to participate in the study as a control or comparison group.
This study is actively enrolling subjects. -
Rebecca Seekamp, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsInterested in complementary/alternative medicine, international health, international adoption medicine and providing full spectrum health care.
-
Luise Avelina Seeker
Basic Life Research Scientist
BioLuise Seeker is a trained vet from Berlin, Germany with a strong interest in researching ageing at a cellular level. She obtained a PhD in Genomics from the University of Edinburgh in 2018 for studying telomeres, their heritability and their power to predict lifespan (supervised by Profs. Georgios Banos, Dan Nussey, Mike Coffey and Bruce Whitelaw). She joined Prof. Anna Williams' lab at the University of Edinburgh as a postdoc and investigated transcriptional changes with ageing in the human central nervous system.
-
Krish Seetah
Associate Professor at the Stanford Doerr School of Sustainability, of Oceans, of Anthropology and Senior Fellow at the Woods Institute for the Environment
BioI am a zooarchaeologist, whose focus is primarily on colonisation and colonialism. My zooarchaeological research has used butchery analysis (with the benefit of professional and ethnographic actualistic experience) to investigate agency within the human-animal relationship. More recently, I have employed geometric morphometrics (GMM) as a mechanism for identifying and distinguishing animal populations. This approach to studying colonial activity centres on understanding how people manipulate animal bodies, both during life and after death.
Alongside the strictly faunal research is a research interest in technologies associated with animal processing. This has been used to investigate issues of technology, trade and socio-economic attitudes within colonial contexts in the Mediterranean (Venice & Montenegro) and the Baltic (Poland, Latvia & Lithuania).
I am also the Director of the ‘Mauritian Archaeology and Cultural Heritage’ (MACH) project, which studies European Imperialism and colonial activity. This project centres on the movement of peoples and material cultures, specifically within the contexts of slavery and Diaspora. The work of this project has focused on key sites in Mauritius and is based on a systematic programme of excavation and environmental sampling. The underlying aims are to better understand the transition from slavery to indentured labour following abolition, the extent and diversity of trade in the region and the environmental consequences of intense, monoculture, agriculture. -
Paul Segall
The Cecil H. and Ida M. Green Professor of Geophysics
Current Research and Scholarly InterestsResearch
I study active earthquake and volcanic process through data collection, inversion, and theoretical modeling. Using methods such as precise Global Positioning System (GPS) positioning and Interferometric Synthetic Aperture Radar (InSAR) we are able to measure deformation in space and time and invert these data for the geometry of faults and magma chambers, and spatiotemporal variations in fault slip-rate and magma chamber dilation. The accumulation of shear strain in tectonic regions provides a direct measure of earthquake potential. Similarly, magma accumulation in the crust prior to eruptions causes measurable inflation. We use these data to develop and test models of active plate boundaries such as the San Andreas, and the Cascade and Japanese subduction zones, the nucleation of earthquakes, slow slip events, induced seismicity, and the physics of magma migration leading to volcanic eruptions. These physics-based models rely on principles and methodologies from solid and fluid dynamics.
Teaching
I teach introductory undergraduate classes in natural hazards and the prediction of volcanic eruptions, as well as graduate level courses on modeling earthquake and volcano deformation and geophysical inverse theory.
Professional Activities
James B. Macelwane Medal, American Geophysical Union (1990); fellow, American Geophysical Union (1990); fellow, Geological Society of America (1997); president, Tectonophysics Section, AGU (2002-04); U.S.G.S. Science of Earthquakes Advisory Committee (2002-06); California Earthquake Prediction Evaluation Committee (2003-07); chair, Plate Boundary Observatory Steering Committee (2003-06); N.S.F. Panel, Instruments and Facilities Program (1997-2000); associate editor, Journal of Geophysical Research (1984-87). William Smith Lecturer, Geological Society of London (2011). Charles A. Whitten Medal, American Geophysical Union (2014), National Academy of Sciences (2016) -
Niraj Sehgal
Clinical Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement & Patient Safety, Teamwork & Communication, Leadership
Development, Organizational Culture & Change -
Carolyn Dacey Seib, MD, MAS
Associate Professor of Surgery (General Surgery)
BioDr. Carolyn Dacey Seib is a fellowship-trained endocrine surgeon and board certified general surgeon. Her practice is focused on surgery of the thyroid, parathyroid, and adrenal glands.
Dr. Seib has clinical and research expertise in the surgical management of endocrine disorders in older adults, including primary hyperparathyroidism, thyroid cancer, and hyperthyroidism. Dr. Seib completed her undergraduate education at Princeton University, graduating summa cum laude in 2004. She received her M.D. at the New York University School of Medicine and then attended residency in General Surgery at UCSF. Dr. Seib also completed a fellowship in Endocrine Surgery at UCSF, during which she cared for patients with complex disorders of the thyroid, parathyroid, and adrenal glands.
Dr. Seib focuses on providing individualized care for patients with thyroid malignancy, hyperthyroidism, primary hyperparathyroidism, and adrenal disorders. She has received funding from the National Institute on Aging and the American Thyroid Association to study the surgical management of endocrine disorders in older adults and has a number of peer-reviewed journal publications on this topic that have received national attention, including being featured in the New York Times. -
Samuel Seidel
Adjunct Professor
BioSam is the K12 Lab Director of Strategy + Research at the Stanford d.school, and co-author of Creative Hustle (Ten Speed Press, 2022), Changing the Conversation About School Safety (Stanford d.school, 2022), Hip Hop Genius 2.0 (Rowman & Littlefield, 2022), and Hip Hop Genius: Remixing High School Education (Rowman & Littlefield, 2011).
He speaks internationally about education, race, culture, systems, and design.
Sam graduated from Brown University with a degree in Education and a teaching certification, was a Visiting Practitioner at Harvard Graduate School of Education, a Scholar-in-Residence at Columbia University's Institute for Urban and Minority Education, and a Community Fellow at the Rhode Island School of Design. -
Ayelet Sela
Civil Justice and Innovation Fellow
BioAyelet Sela is the Civil Justice and Innovation Fellow at the Deborah L. Rhode Center on the Legal Profession at Stanford Law School. She is also a lecturer (assistant professor) at the Faculty of Law in Bar Ilan University (currently on sabbatical). Dr. Sela’s scholarship and teaching revolve around dispute system design, law and technology, courts, and empirical legal studies. Her recent academic work focuses on procedural design, procedural justice and access to justice in online courts and tribunals as well as in hybrid (remote) proceedings. She is particularly interested in exploring how the justice system can best serve self-represented individuals in these contexts. In addition, Dr. Sela collaborates with data scientists on the application of machine learning methods to legal data and studies questions related to the use of AI tools in governance mechanisms and judicial contexts. Previously, Dr. Sela was a senior fellow of the Jean Monett Center on Digital Governance, a founding member of the BIU LawData Lab, and a member of the Bar-Ilan University Data Science Institute. She also clerked for the Honorable Justice Eliezer Rivlin in the Israeli Supreme Court and worked as an auditor for the Israeli Ministry of Justice. Dr. Sela holds a JSD and JSM from Stanford Law School and an LL.B and “Amirim” Honors Program diploma from the Hebrew University in Jerusalem.
-
Serdar Selamet
Visiting Assoc Prof
BioAssoc. Professor with focus on Fire Engineering, Steel Structures and Numerical Modeling.
-
Zachary M. Sellers, MD, PhD
Adjunct Professor, Pediatrics - Gastroenterology
BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.
-
Deborah Sellmeyer
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
-
Subhro K. Sen, MD
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioSubhro K. Sen, MD, Clinical Associate Professor in the Division of Plastic and Reconstructive Surgery, graduated from Northwestern University with a degree in biomedical engineering. He went on to receive his medical degree from the Northwestern University Feinberg School of Medicine. After medical school, he completed a yearlong peripheral nerve research fellowship under Dr. Susan Mackinnon at the Washington University School of Medicine in St. Louis. He completed his postgraduate training in general surgery at Indiana University, followed by plastic and reconstructive surgery at Johns Hopkins University. He finished his training with a hand and upper extremity surgery fellowship at Stanford University.
Dr. Sen’s general clinical interests are in reconstructive surgery, microvascular surgery, and hand and upper extremity surgery. His practice includes: post-traumatic extremity reconstruction; post-oncologic reconstruction of the head and neck, trunk and extremities; perforator flap surgery; and melanoma surgery. He is medical director of the Advanced Wound Care Center at Stanford Health Care. As a hand surgeon in the Robert A. Chase Hand and Upper Limb Center, he has interests in hand trauma, degenerative conditions, peripheral nerve injuries, and complex upper extremity flap reconstruction.
In addition to his clinical practice, Dr. Sen is involved in research, publication, and teaching. His peer-reviewed research includes studies on extremity reconstruction, peripheral nerve regeneration, and he has authored a number of book chapters on a variety of plastic and hand surgery topics. He has a strong interest in medical device innovation and is currently a faculty fellow in the Stanford Byers Center for Biodesign.
Dr. Sen is certified by the American Board of Plastic Surgery and the American Board of Surgery. He is a member of the American Society of Plastic Surgeons, the American Society for Surgery of the Hand, and the American Society of Reconstructive Microsurgery. -
Debbie Senesky
Associate Professor of Aeronautics and Astronautics, of Electrical Engineering and Senior Fellow at the Precourt Institute for Energy
BioDebbie G. Senesky is an Associate Professor at Stanford University in the Aeronautics and Astronautics Department and the Electrical Engineering Department. In addition, she is the Principal Investigator of the EXtreme Environment Microsystems Laboratory (XLab). Her research interests include the development of nanomaterials for extreme harsh environments, high-temperature electronics for Venus exploration, and microgravity synthesis of nanomaterials. In the past, she has held positions at GE Sensing (formerly known as NovaSensor), GE Global Research Center, and Hewlett Packard. She received the B.S. degree (2001) in mechanical engineering from the University of Southern California. She received the M.S. degree (2004) and Ph.D. degree (2007) in mechanical engineering from the University of California, Berkeley. Prof. Senesky is the Site Director of nano@stanford. She is currently the co-editor of two technical journals: IEEE Journal of Microelectromechanical Systems and Sensors. In recognition of her research, she received the Emerging Leader Abie Award from AnitaB.org in 2018, Early Faculty Career Award from the National Aeronautics and Space Administration (NASA) in 2012, Gabilan Faculty Fellowship Award in 2012, and Sloan Ph.D. Fellowship from the Alfred P. Sloan Foundation in 2004.
Prof. Senesky's career path and research has been featured by Scientific American, Seeker, People Behind the Science podcast, The Future of Everything radio show, Space.com, and NPR's Tell Me More program. More information about Prof. Senesky can be found at https://xlab.stanford.edu and on Instagram (@astrodebs). -
Yasir Sepah
Assistant Professor (Research) of Ophthalmology
Current Research and Scholarly InterestsYasir's primary focus is on early identification of ocular diseases and objective assessment of response to therapy via biomarker (imaging and molecular) discovery and endpoints development for clinical trials. His lab is also developing and implementing protocols and methods to make decentralized clinical trials in ophthalmology viable.
Yasir is also engaged in developing low-tech, low cost and less intelligent solutions in order to improve patient's access to care. -
Shebani Sethi MD, ABOM
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsImproving metabolic and mental health through dietary metabolic therapies, pharmacological optimization, and other lifestyle interventions in those with severe mental illness, such as bipolar disorder, schizophrenia, major depression is a major focus of her research. Clinical and academic interests include management of psychiatric disorders with co-morbid obesity, insulin resistance, metabolic dysfunction and/or eating disorders, particularly binge eating disorder and bulimia nervosa.
-
Kawin Setsompop
Associate Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioKawin Setsompop is an Associate Professor of Radiology and, by courtesy, of Electrical Engineering. His research focuses on the development of novel MRI acquisition methods, with the goal of creating imaging technologies that can be used to help better understand brain structure and function for applications in Healthcare and Health sciences. He received his Master’s degree in Engineering Science from Oxford University and his PhD in Electrical Engineering and Computer Science from MIT. Prior to joining Stanford, he was a postdoctoral fellow and subsequently a faculty at the A.A. Martinos center for biomedical imaging, MGH, as well as part of the Harvard and MIT faculty. His group has pioneered several widely-used MRI acquisition technologies, a number of which have been successfully translated into FDA-approved clinical products on Siemens, GE, Phillips, United Imaging and Bruker MRI scanners worldwide. These technologies are being used daily to study the brain in both clinical and neuroscientific fields.
-
Sharon Sha, MD, MS
Clinical Professor, Neurology & Neurological Sciences
BioDr. Sha is a Clinical Professor of Neurology and Neurological Sciences at Stanford University where she serves as Chief for the Memory Disorders Division and the Stanford Memory Disorders Center, Associate Vice Chair of Clinical Research, Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center, and Director of the Behavioral Neurology Fellowship. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders and her research is devoted to finding treatments for these cognitive disorders. She also served on the California Governor’s Alzheimer’s Prevention and Preparedness Task Force Chaired by Maria Shriver in 2020. She has been featured in international media and documentaries such as the BBC "How to Stay Young" and the Docuseries "Limitless with Chris Hemsworth".
-
Ross Shachter
Associate Professor of Management Science and Engineering
Current Research and Scholarly InterestsProf. Shachter's research has focused on the representation, manipulation, and analysis of uncertainty and probabilistic reasoning in decision systems. As part of this work, he developed the DAVID influence diagram processing system for the Macintosh. He has developed models scheduling patients for cancer follow-up, and analyzing vaccination strategies for HIV and Helobacter pylori.
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
On Leave from 05/01/2024 To 10/31/2024Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioI joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine, having completed my training in Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. My areas of clinical expertise have been in the areas of transplantation for immune deficiencies and immune reconstitution post HSCT. I have been actively involved with the care and treatment of children with primary immune deficiencies and work with the Primary Immune Deficiencies Consortium (PIDTC). I am very interested in cellular therapies as a treatment modality for rare genetic diseases. I currently am the PI for several gene therapy trials at Stanford for various disorders including cerebral adrenoleukodystrophy (cALD), Sickle Cell Anemia, Thalassemia and Pyruvate Kinase Deficiency. My other main areas of research have been in studying the late effects of patients following stem cell transplantation, in specific the neurocognitive function post HSCT. I have been involved with several national committees addressing the late effects of HSCT within the ASBMT and COG.
In addition to my research work in stem cell transplantation, I have been actively involved with mentorship and graduate medical education. I am currently the Program Director for the Hematology/ Oncology Fellowship and serve as a mentor through the Pediatric Mentoring Group. -
Atulkumar T. Shah, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care’s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.
Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.
Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.
After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a “one-stop” resource for truly comprehensive care.
Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.
Among Dr. Shah’s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.
Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.
As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India. -
Mamta Madhav Shah, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
She provides care for patients with a variety of kidney-related conditions, with a special interest in management of kidney stones and related conditions. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given several talks on kidney stones to trainees and peers. Dr. Shah previously served as medical director of one of the dialysis clinics at University of Connecticut Health Center and helped run the plasmapheresis treatments.
Some of Dr. Shah’s recent research is focused on efforts to prevent filter failure when performing membrane-based therapeutic plasma exchange—a blood purification treatment for removing large molecular weight substances from plasma.
Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.
Dr. Shah is a member of the American Society of Nephrology. She has a keen interest in education of trainees including medical students, residents and fellows; and served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center.
She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and daughter. -
Manish I. Shah, MD, MS
Professor of Emergency Medicine (Pediatrics)
BioI have dedicated my career to improving pediatric prehospital care on local, statewide, national, and international levels through research, education, and advocacy. My primary research interest focuses on integration of pediatric evidence into emergency medical services (EMS) systems. I serve on the Executive Committee of the Pediatric Emergency Care Applied Research Network (PECARN) as the nodal Principal Investigator (PI) for the Charlotte, Houston, and Milwaukee Prehospital (CHaMP) research node. In addition, I am the PI for the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) clinical trial and co-investigator for the Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART). As an educational researcher, I have obtained several grants to produce an online EMS educational resource for physicians, create the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program, and study the implementation of an EMS training curriculum for the Botswana Ministry of Health. As an EMS advocate, I led the Prehospital and State Partnership domains for the national EMS for Children (EMSC) Innovation and Improvement Center (EIIC), served as an appointed member of the National Emergency Medical Services Advisory Council (NEMSAC), chaired the EMS subcommittee for the American Academy of Pediatrics Section of Emergency Medicine, and directed the EMSC State Partnership in Texas. I have published policy on pediatric readiness in EMS systems and co-chaired the workgroup that created the first-ever national assessment of pediatric readiness of EMS systems for the National Prehospital Pediatric Readiness Project (PPRP).
-
Mona D. Shah, MD, MBA
Adjunct Clinical Associate Professor, Pediatrics - Hematology & Oncology
BioDr. Mona Shah is a pediatric hematologist-oncologist, who earned her MD degree at the University of Maryland in 2001. She completed both her categorical pediatrics and global health residencies in 2004, followed by a pediatric hematology-oncology fellowship in 2007. She earned her MS in Clinical Investigation as part of the Clinical Scientist Training Program (CSTP) at Baylor College of Medicine in 2011, and more recently, completed an Executive MBA at Rice University Jones School of Business in 2018.
Dr. Shah was an Associate Professor at Baylor College of Medicine (2007 - 2020) in both Pediatrics and Medicine, local site PI on a number of pediatric hemostasis/thrombosis clinical trials, and spent 10 years as an Associate Medical Director of Clinical Operations, Quality, and Safety at Texas Children’s Hospital, Houston, TX.
Dr. Shah joined Genentech (a Member of the Roche Group)’s Rare Blood Disorders Franchise (Product Development - Oncology-Hematology) in February 2020, quickly advancing to Lead Medical Director, where she served as Medical Monitor for 2 Phase III Clinical Trials (crovalimab in atypical hemolytic uremic syndrome, aHUS). She was also engaged with the Renal Franchise (I2O) in developing crovalimab in Lupus Nephritis (Phase I & II Clinical Trials in development), and with Human Factors/Pediatric Formulations Working Group on autoinjector devices and oral formulations.
After completing a rotation in Early Development Safety (EDS), she was promoted to Senior Medical Safety Director in Late Stage Product Development, and was appointed Safety Strategy Lead for giredestrant in early and metastatic breast, ovarian, and endometrial cancer global clinical trials. She has experience in innovative study designs (adaptive/multi-drug), with FDA/EMA pediatric investigational plans, and health authority interactions. In June 2023, she was appointed Pediatric Safety Lead, in collaboration with the iPODD Team, supporting safety for pediatric indications and devices, and serves as the Co-Chair of the Pediatric Safety Expert Group.
Dr. Shah has kept and completed a bucket list since she was 7 years old (keeps growing): Running wild bouldering/rock climbing as a child in the Shenandoah/Blue Ridge Mountains, swimming with dolphins/piranhas in the Amazon, climbing inside a volcano caldera in Iceland, snorkeling the Great Barrier Reef ... have passport/will travel!
Since July 2022, she has joined Stanford University School of Medicine, as an Adjunct Clinical Associate Professor in the Department of Pediatrics, Division of Hematology-Oncology, where she enjoys teaching MSII students, and at the bedside in the Lucille Packard Bass Center Hematology Clinic. Dr. Shah enjoys free time in her new home base near San Francisco, where she hosts her visiting parents, friends, and extended family. -
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsWe analyze multiple types of health data (EHR, Claims, Wearables, Weblogs, and Patient blogs), to answer clinical questions, generate insights, and build predictive models for the learning health system.
-
Nirao Shah
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Rajesh Shah
Clinical Associate Professor, Radiology
BioI am an interventional radiologist with a particular interest in interventional oncology. I perform a wide range of procedures including ablations of the lung, liver, kidney, bone, and other areas in the body, chemoembolization, embolization, and radioembolization of tumors, biopsies, drainages, and interventions on both the venous and arterial sides. I was the first physician to perform SIR-spheres radioembolization for metastatic tumors to the liver within the VA hospital system, and have been recognized for my teaching of trainees. I am currently the Director of Interventional Radiology and Associate Chief of Radiology at the VA Palo Alto Health Care System. My research focuses on HCC and Lung cancer, including the application of Machine Learning/AI and Radiogenomics to lung cancer identification, and improving tools to treat liver cancer. I also work on Quality in Medicine as the Councilor of the Quality and Performance Improvement Division for the Society of Interventional Radiology where we work to define quality measures, gather data via a national IR registry, and develop practice improvement tools. In this role, I have led the development and launch of the VIRTEX Registry which is the primary clinical data registry for the field of Interventional Radiology.
-
Rajan Lalit Shah
Affiliate, Medicine - Med/Cardiovascular Medicine
BioDr. Rajan Shah is a cardiac electrophysiologist concentrating on the treatment of arrhythmias, especially those of complex origins. He prides himself on delivering personalized attention, compassion, and high-quality care to optimize the needs of his patients with abnormal heart rhythms. His experiences in Detroit, where he was raised, exposed him to a wide range of beautiful cultures and backgrounds, and solidified his decision to pursue a career focused on the wellbeing of people.
He completed his sub-specialty fellowship at Stanford University where he received 2 years of highly specialized training dedicated to the treatment of genetic arrhythmia syndromes and management of complex heart rhythm disorders. Dr. Shah continues his profession at Stanford Health Care and is grateful for the opportunity to care for a diverse population, employing his expertise in state-of-the-art therapies including minimally-invasive catheter ablation (ex: ventricular tachycardia, atrial fibrillation) and device implantation (ex: conduction system and leadless pacing) to better the health outcomes of his patients with various arrhythmias. In his clinical role, Dr. Shah additionally directs the East Bay Familial Inherited Arrhythmia Clinic concentrated on the tailored-treatment of genetic arrhythmia syndromes and the prevention of sudden cardiac death in individuals and families. -
Ripal Shah
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, supplements, exercise, behavioral modifications, hypnosis), and in physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians). Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, diversity & inclusion program development, ethnicity-dependent variability in mental health access and treatment response, psychedelics, spirituality, and minority stress. Her lab also studies the role of Eastern religions on mental health in the U.S., and the connection between Hinduism and psychedelics. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation), as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, she served as Chief Resident and led community partnerships and DEI efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for programs across the country, built and then graduated from a Diversity & Health Equity track in the residency, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry.
She is board certified in Adult Psychiatry, Addiction Medicine, and Obesity Medicine, and board-eligible in Integrative Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. She is credentialed as one of very few physicians in the country able to bill for TMS (transcranial magnetic stimulation), ECT (electroconvulsive therapy), hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD). She advises several companies and research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
Sejal Shah
Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah specializes in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. He also serves as an investigator on numerous clinical trials, with a focus on novel immunotherapy agents. His academic interests also include digital health technologies and novel healthcare delivery services, both in the domestic and international setting. Dr. Shah graduated with distinction in biomedical engineering from Duke University, received his medical doctorate from Stanford University, and Masters in Public Health from Harvard University. He completed his internal medicine residency at the University of California, San Francisco (UCSF) where he stayed on faculty for one year before returning to Stanford for his fellowship training in medical oncology, where he now serves on the faculty.
-
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD currently serves as Chief of the Medical Staff for Stanford Health Care. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine. His clinical focus is on bladder cancer, and he is well known for his expertise in robotic surgery. His academic interests center on optimizing outcomes after bladder removal surgery. He is very active in leadership development, team building, and quality improvement work and he lectures nationally and internationally on these topics. He is also certified by the International Coaching Federation as an executive coach.
Dr. Shah graduated from Harvard College, and he completed medical school and urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center and then joined the faculty there. During his time at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, and exploring the beaches of Northern California with his family and three dogs.
In his free time, Dr. Shah enjoys reading, cooking, surfing, hiking and exploring the beaches of Northern California in his Jeep Wrangler with his family and 2 dogs. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioWith a primary focus on high-dimensional data, I have significant expertise in developing machine learning tools. Much of my work involves constructing Bayesian models, which effectively convert 'prior knowledge', either inherent in the dataset or obtained from external sources, into mathematical terms—more specifically, prior probabilities.
My recent research efforts have centered on the analysis of genetic and epigenetic signals within cell-free DNA assays. This interest in epigenetics led to the development of a pioneering technique known as EPIC-seq, which has broadened our understanding of this complex field.
It's notable that traditional computational methods in cancer genomics often fall short when confronted with an exceedingly low signal-to-noise ratio—a common scenario in cfDNA analyses. As such, there's an emerging need to devise innovative, robust methods capable of overcoming this limitation—a research area that I'm deeply committed to and actively engaged in.
